DK1383796T3 - Neurovirulent stamme af viruset West Nile og anvendelser heraf - Google Patents

Neurovirulent stamme af viruset West Nile og anvendelser heraf

Info

Publication number
DK1383796T3
DK1383796T3 DK02759815T DK02759815T DK1383796T3 DK 1383796 T3 DK1383796 T3 DK 1383796T3 DK 02759815 T DK02759815 T DK 02759815T DK 02759815 T DK02759815 T DK 02759815T DK 1383796 T3 DK1383796 T3 DK 1383796T3
Authority
DK
Denmark
Prior art keywords
applications
west nile
nile virus
neurovirulent strain
neurovirulent
Prior art date
Application number
DK02759815T
Other languages
English (en)
Inventor
Vincent Deubel
Jean-Louis Guenet
Marie-Pascale Frenkiel
Fasseli Coulibaly
Adeline Catteau
Marie Flamand
Patrick Weber
Pierre-Emmanuel Ceccaldi
Philippe Despres
Marie-Therese Drouet
Mertyn Malkinson
Caroline Banet
Marie-Pierre Courageot
Original Assignee
Pasteur Institut
Kimron Veterinary Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26212954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1383796(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0104599A external-priority patent/FR2823218B1/fr
Priority claimed from FR0111525A external-priority patent/FR2829149B1/fr
Application filed by Pasteur Institut, Kimron Veterinary Inst filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK1383796T3 publication Critical patent/DK1383796T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK02759815T 2001-04-04 2002-04-04 Neurovirulent stamme af viruset West Nile og anvendelser heraf DK1383796T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0104599A FR2823218B1 (fr) 2001-04-04 2001-04-04 Souche neurovirulente du virus west nile et ses applications
FR0111525A FR2829149B1 (fr) 2001-09-06 2001-09-06 Souche neurovirulente du virus west nile et ses applications
PCT/FR2002/001168 WO2002081511A1 (fr) 2001-04-04 2002-04-04 Souche neurovirulente du virus west-nile et ses applications

Publications (1)

Publication Number Publication Date
DK1383796T3 true DK1383796T3 (da) 2009-08-17

Family

ID=26212954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02759815T DK1383796T3 (da) 2001-04-04 2002-04-04 Neurovirulent stamme af viruset West Nile og anvendelser heraf

Country Status (9)

Country Link
EP (1) EP1383796B2 (da)
AT (1) ATE428725T1 (da)
CA (1) CA2443290C (da)
CY (1) CY1109244T1 (da)
DE (1) DE60231970D1 (da)
DK (1) DK1383796T3 (da)
ES (1) ES2327217T5 (da)
PT (1) PT1383796E (da)
WO (1) WO2002081511A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004055159A2 (en) * 2002-12-12 2004-07-01 Chiron Corporation Identification of oligonucleotides for the capture, detection and quantitation of west nile virus
BRPI0408967B8 (pt) 2003-03-31 2021-07-27 Hoffmann La Roche kit e métodos para detecção de um ácido nucléico de vários membros do sorogrupo do vírus da encefalite japonesa em uma amostra biológica sob condições de hibridização rigorosas
CA2793127A1 (en) * 2003-11-12 2005-05-26 Bayer Healthcare Llc Oligonucleotides and methods for detection of west nile virus
RU2265658C2 (ru) * 2004-01-09 2005-12-10 Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") Штамм гибридных клеток животного mus musculus l. 9e2, используемый для получения моноклональных антител к белку e вируса западного нила штамм wnv/leiv-vig99-27889
FR2870126B1 (fr) 2004-05-17 2009-07-17 Pasteur Institut Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin
EP2473624B1 (en) 2009-08-31 2019-05-01 Gen-Probe Incorporated Dengue virus assay
RU2595429C1 (ru) * 2015-04-21 2016-08-27 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") ШТАММ ГИБРИДНЫХ КЛЕТОК ЖИВОТНОГО Mus musculus L. 5Н6 - ПРОДУЦЕНТ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ДЛЯ ВЫЯВЛЕНИЯ ГЛИКОПРОТЕИНА Е ВИРУСА ЗАПАДНОГО НИЛА, МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА 5Н6, ПРОДУЦИРУЕМЫЕ УКАЗАННЫМ ШТАММОМ ГИБРИДНЫХ КЛЕТОК, И ИММУНОФЕРМЕНТНЫЙ НАБОР ДЛЯ ВЫЯВЛЕНИЯ ГЛИКОПРОТЕИНА Е ВИРУСА ЗАПАДНОГО НИЛА С ИСПОЛЬЗОВАНИЕМ УКАЗАННЫХ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1102605A1 (ru) * 1982-05-05 1984-07-15 Войсковая Часть 41598 Способ получени диагностического иммуноглобулина к вирусу Западного Нила

Also Published As

Publication number Publication date
EP1383796A1 (fr) 2004-01-28
ES2327217T3 (es) 2009-10-27
EP1383796B2 (fr) 2012-08-22
PT1383796E (pt) 2009-07-21
WO2002081511A1 (fr) 2002-10-17
CA2443290C (fr) 2011-11-08
EP1383796B1 (fr) 2009-04-15
ES2327217T5 (es) 2013-02-11
DE60231970D1 (de) 2009-05-28
CA2443290A1 (fr) 2002-10-17
CY1109244T1 (el) 2014-07-02
ATE428725T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
DK1332209T3 (da) Samlinger af repeatproteiner indeholdende repeatmoduler
PL1685243T3 (pl) Unieśmiertelnione ptasie linie komórkowe do wytwarzania wirusów
EP1373296A4 (en) PROTEINS THAT AFFORD MODIFIED IMMUNOGENIC REACTIONS, AND METHOD FOR THEIR PREPARATION AND APPLICATION
FR2822164B1 (fr) Polypeptides derives des arn polymerases, et leurs utilisations
WO2005056584A3 (fr) Nouvelle souche de coronavirus associe au sras et ses applications.
CY1106334T1 (el) Βελτιστοποιημενου κωδικονιου αλληλουχιες ιου θηλωματος
DE60335350D1 (de) Adjuvantien für dns impstoffe basierend auf imidazochinoline
CY1110793T1 (el) Εμβολιο φυματιωσης με βελτιωμενη αποτελεσματικοτητα
TW200508246A (en) Anti-dengue virus antibodies, compositions, methods and uses
SG156690A1 (en) Mammalian genes involved in infection
DK1390543T3 (da) Nye polynukleotider og polypeptider af IFNalfa-17-genet
EA200601043A1 (ru) Промоторы для экспрессии в модифицированном вирусе осповакцины штамма анкара
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
DK1383796T3 (da) Neurovirulent stamme af viruset West Nile og anvendelser heraf
WO2002027007A3 (en) Production of viral vectors
DE60034884D1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
ATE529441T1 (de) Expression von proteinen in e.coli
DE60040219D1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
WO2007084488A3 (en) Adam10 and its uses related to infection
DK1756273T3 (da) Signalpeptid til frembringelse af et polypeptid
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
DE50214936D1 (de) Verwendung des adenoviralen e2-late-promotors
ATE414905T1 (de) Diabetesmodell
BR0010222A (pt) Vetores de expressão viral
ATE447008T1 (de) Rre und cte umfassende gentechnische konstrukte und zusammensetzungen und verwendungen davon